Forecast 2025
Member Exclusive
Congress Looks to Move BIOSECURE Act
Key Takeaways
- A bill to limit US exposure to Chinese biotech firms has been introduced in the House and Senate.
- BIOSECURE would cast a wide net, including by prohibiting the federal government from entering into contracts with US companies that do business with designated Chinese biotech firms.
- The bill could find itself in the annual defense package as lawmakers negotiate a path forward.
